Medexus Pharmaceuticals Inc.
MEDXF
$2.39
$0.104.15%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 14.98M | 9.38M | 9.33M | 23.97M | 8.44M |
| Total Receivables | 11.83M | 12.08M | 12.36M | 13.31M | 14.14M |
| Inventory | 31.30M | 34.23M | 35.40M | 39.82M | 34.00M |
| Prepaid Expenses | 11.86M | 6.74M | 7.13M | 3.10M | 9.77M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 376.00K | 369.00K |
| Total Current Assets | 69.97M | 62.43M | 64.22M | 80.57M | 66.72M |
|
|
|||||
| Total Current Assets | 69.97M | 62.43M | 64.22M | 80.57M | 66.72M |
| Net Property, Plant & Equipment | 457.00K | 507.00K | 573.00K | 689.00K | 712.00K |
| Long-term Investments | 10.22M | 10.15M | 10.24M | 10.00M | 9.99M |
| Goodwill | 10.22M | 10.15M | 10.24M | 10.00M | 9.99M |
| Total Other Intangibles | 64.78M | 67.06M | 69.52M | 71.60M | 59.29M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.56M | 9.30M | 9.24M | 8.98M | 9.26M |
| Total Assets | 154.98M | 149.44M | 153.79M | 171.84M | 145.98M |
|
|
|||||
| Total Accounts Payable | 43.38M | 37.69M | 39.69M | 5.73M | 39.75M |
| Total Accrued Expenses | -- | -- | -- | 35.29M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.20M | 20.95M | 21.74M | 36.98M | 17.75M |
| Total Finance Division Other Current Liabilities | 11.82M | 16.31M | 17.47M | 19.31M | 8.85M |
| Total Other Current Liabilities | 11.82M | 16.31M | 17.47M | 19.31M | 8.85M |
| Total Current Liabilities | 62.40M | 74.94M | 78.89M | 97.31M | 66.35M |
|
|
|||||
| Total Current Liabilities | 62.40M | 74.94M | 78.89M | 97.31M | 66.35M |
| Long-Term Debt | 18.08M | -101.00K | -- | -- | 21.74M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 76.00K | 219.00K | 159.00K | 198.00K | 430.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 22.22M | 21.96M | 21.78M | 22.19M | 24.36M |
| Total Liabilities | 102.77M | 97.02M | 100.83M | 119.70M | 112.88M |
|
|
|||||
| Common Stock & APIC | 107.77M | 108.15M | 108.28M | 108.11M | 88.69M |
| Retained Earnings | -61.71M | -61.79M | -61.48M | -62.00M | -61.44M |
| Treasury Stock & Other | 6.15M | 6.06M | 6.16M | 6.03M | 5.85M |
| Total Common Equity | 52.21M | 52.42M | 52.96M | 52.14M | 33.10M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 52.21M | 52.42M | 52.96M | 52.14M | 33.10M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 52.21M | 52.42M | 52.96M | 52.14M | 33.10M |
|
|
|||||